Area of research
Biomedical Engineering · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Medicine, Ejection fraction, Heart failure, Internal medicine, Peripartum cardiomyopathy, and Cardiology.
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
DIGitoxin to Improve Outcomes in Patients with Advanced Chronic Heart Failure (DIGIT-HF): Baseline Characteristics Compared to Recent Randomized Controlled Heart Failure Trials
The DIGIT-HF Trial: Key Amendments of Study Design
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial
Augmented NETT regularization of inverse problems
Experimental lung injury induces cerebral cytokine mRNA production in pigs
Sparse Anett For Solving Inverse Problems With Deep Learning
Rationale and Design of the DIGIT-HF Trial (DIGitoxin to Improve Outcomes in Patients with Advanced Chronic Heart Failure): A Randomized, Double-Blind, Placebo-Controlled Study
Long-Term Follow-up in Peripartum Cardiomyopathy Patients with Contemporary Treatment: Low Mortality, High Cardiac Recovery, but Significant Cardiovascular Co-Morbidities
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
Prognostic Implication of Right Ventricular Involvement in Peripartum Cardiomyopathy: A Cardiovascular Magnetic Resonance Study
Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathy